Inhibrxの売上総利益
Inhibrxの売上総利益 は何ですか。
Inhibrx, Inc.の売上総利益 は100.00%です。
売上総利益 の定義は何ですか。
売上総利益は、売上と商品の売上原価との差を収益で除してパーセンテージで表したものです。
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
NASDAQのセクタHealth Careにおける売上総利益 の企業と比べるInhibrx
Inhibrxは何をしますか。
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.
Inhibrxと類似の売上総利益
- Zenkoku Hosho Coの売上総利益 は99.99%です。
- Damartex SAの売上総利益 は100.00%です。
- Consolidated Finvest &の売上総利益 は100.00%です。
- McDowellの売上総利益 は100.00%です。
- Vanguard Specialized Funds - Vanguard Real Estate ETFの売上総利益 は100.00%です。
- BlackRock MuniVest Fundの売上総利益 は100.00%です。
- Inhibrxの売上総利益 は100.00%です。
- CRCAM Loire Haute-Loireの売上総利益 は100.00%です。
- iShares Trust - iShares Core S&P 500 ETFの売上総利益 は100.00%です。
- Clean Power Capitalの売上総利益 は100.00%です。
- Investec plcの売上総利益 は100.00%です。
- Atlas Maraの売上総利益 は100.00%です。
- Huarong Internationalの売上総利益 は100.00%です。